Not all clients with CLL involve therapy. In spite of all recent advances, the iwCLL nonetheless suggests watchful observation for people with asymptomatic disorder.86 This advice is based on at the very least two randomized trials comparing observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104